St.Gallen International Breast Cancer Conference

A team of investigators aimed to determine the incremental breast cancer detection rates associated with conventional breast imaging techniques.

A team of investigators sought to identify the level of adherence to medical standards and its association with the recurrence rate of breast cancer.

A team of investigators conducted a retrospective, population-based, matched-cohort study to assess outcomes in young women who were diagnosed with early-stage breast cancer.

Results from the phase 3 monarchE trial on the addition of abemaciclib to endocrine therapy in patients with early breast cancer were presented at the 17th St. Gillen International Breast Cancer Conference.

A team of researchers sought to assess outcomes related to hypofractionated whole breast radiation following breast-conserving surgery in women aged younger than 50 years.

A team of investigators sought to determine the significance of the immunologic aspects of the antitumor response and reported their findings at the 17th St. Gillen International Breast Cancer Conference 2021.

Locoregional treatment improved survival for patients with de novo stage IV breast cancer and bone only metastasis compared with systemic treatment.

A team of investigators assessed the efficacy of trastuzumab in early-stage breast cancer and presented their research at the 17th St. Gallen International Breast Cancer Conference 2021.

A team of investigators sought to evaluate safety, tolerability, and antitumor activity neoadjuvant niraparib for patients with localized breast cancer.

A team of investigators sought to identify the most accurate preoperative breast imaging technique for determining tumor size in individuals with early breast cancer.